ACCESSING CLASSIFIED FILES
Decrypting documents...
Your connection is being monitored
ACCESSING CLASSIFIED FILES
Decrypting documents...
Your connection is being monitored

FDA examiner who approved OxyContin's label claiming low addiction risk, then took a job at Purdue Pharma
FDA examiner who approved OxyContin's label claiming low addiction risk, then took a job at Purdue Pharma
Curtis Wright. Profile pending review.
Connected to 1 documented investigation
Network analysis reveals Curtis Wright holds overlapping roles across multiple entities with conflicting interests, creating accountability gaps that shield questionable activities from public scrutiny.
Court documents from related proceedings reference Curtis Wright as a key decision-maker during periods where regulatory violations were later documented.
FDA official who approved OxyContin then joined Purdue consulting
1 documented sources from official records, investigations, and reports
Ongoing
Active in role as FDA examiner who approved OxyContin